TriSalus Life Sciences receives FDA clearance for TriNav Advance device
Go back to TriSalus Life Sciences receives FDA clearance for TriNav Advance device| (NASDAQ: TLSI) | Delayed: 3.72 +0.19 (5.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.53 | 52 Week High | $ | |||
| Open | $3.57 | 52 Week Low | $ | |||
| Day High | $3.72 | P/E | N/A | |||
| Day Low | $3.57 | EPS | $ | |||
| Volume | 57,702 | |||||



